Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

1
Player Avatar MarkP28665 (37.95) Submitted: 12/21/2011 8:33:02 PM : Outperform Start Price: $32.91 VRTX Score: +91.06

Promising Pipeline

Report this Post Reply

Featured Broker Partners


Advertisement